Cancer Network spoke with Marleen Meyers, MD, about evidence on low-dose tamoxifen vs placebo in women who had surgery for their ductal carcinoma in situ.
Marleen Meyers, MD
Advertisement
Articles by Marleen Meyers, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Grants Priority Review to T-DXd in HER2+ Early Breast Cancer
2
Elucidating Treatment Selection for Metastatic HSPC at ASCO GU 2026
3
Rolling NDA Submission Completed for Zipalertinib in EGFR+ NSCLC
4
FDA Issues CRL for Retifanlimab/Chemotherapy in Metastatic NSCLC
5